These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 24993341

  • 1. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
    Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML.
    Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
    [Abstract] [Full Text] [Related]

  • 2. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML.
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [Abstract] [Full Text] [Related]

  • 3. Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats.
    Qi ZG, Zhao X, Zhong W, Xie ML.
    Pharm Biol; 2016 Sep; 54(5):882-8. PubMed ID: 26455539
    [Abstract] [Full Text] [Related]

  • 4. PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.
    Zhao X, Wang F, Zhou R, Zhu Z, Xie M.
    Inflammopharmacology; 2018 Apr; 26(2):425-433. PubMed ID: 28236037
    [Abstract] [Full Text] [Related]

  • 5. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
    Qi Z, Xue J, Zhang Y, Wang H, Xie M.
    Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
    [Abstract] [Full Text] [Related]

  • 6. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 7. Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.
    Zhang Y, Xie M, Xue J, Gu Z.
    Planta Med; 2007 Jul; 73(8):718-24. PubMed ID: 17611927
    [Abstract] [Full Text] [Related]

  • 8. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T, Zhu J, Zhu L, Cheng M.
    Nutrients; 2017 Feb 27; 9(3):. PubMed ID: 28264426
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 27; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes.
    Zhao X, Xue J, Xie M.
    Exp Gerontol; 2019 May 27; 119():7-13. PubMed ID: 30659956
    [Abstract] [Full Text] [Related]

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 27; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R, Zhang J, Li C, Zhang X, Xiong A, Huang F, Yin Z, Li K, Qin W, Chen M, Zhang S, Liang L, Zhang H, Nie H, Ye W.
    Arch Pharm Res; 2012 Jul 27; 35(7):1241-50. PubMed ID: 22864747
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease.
    Hsu JY, Lin HH, Hsu CC, Chen BC, Chen JH.
    Nutrients; 2018 Jul 20; 10(7):. PubMed ID: 30037014
    [Abstract] [Full Text] [Related]

  • 17. [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats].
    Shen WD, Zhang W, Xu QH, Liu PF.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct 20; 24(10):749-754. PubMed ID: 27938560
    [Abstract] [Full Text] [Related]

  • 18. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Karsdal MA, Brockbank S, Cruwys S.
    Biomed Pharmacother; 2019 Mar 20; 111():926-933. PubMed ID: 30841472
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
    Zhou C, Zhou J, Han N, Liu Z, Xiao B, Yin J.
    Int Immunopharmacol; 2015 Mar 20; 25(1):218-28. PubMed ID: 25661699
    [Abstract] [Full Text] [Related]

  • 20. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
    Cui WX, Yang J, Chen XQ, Mao Q, Wei XL, Wen XD, Wang Q.
    Am J Chin Med; 2013 Mar 20; 41(3):487-502. PubMed ID: 23711137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.